Rose, P. G., Java, J. J., Morgan, M. A., Secord, A. A., Kesterson, J. P., Stehman, F. B., . . . Copeland, L. J. (2016). Disease Extent at Secondary Cytoreductive Surgery is Predictive of Progression-free and Overall Survival in Advanced Stage Ovarian Cancer: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol.
Chicago Style citaatRose, Peter G., et al. "Disease Extent At Secondary Cytoreductive Surgery Is Predictive of Progression-free and Overall Survival in Advanced Stage Ovarian Cancer: An NRG Oncology/Gynecologic Oncology Group Study." Gynecol Oncol 2016.
MLA citatieRose, Peter G., et al. "Disease Extent At Secondary Cytoreductive Surgery Is Predictive of Progression-free and Overall Survival in Advanced Stage Ovarian Cancer: An NRG Oncology/Gynecologic Oncology Group Study." Gynecol Oncol 2016.